150 related articles for article (PubMed ID: 2193849)
1. The effect of short versus long exposure times of argon laser panretinal photocoagulation on proliferative diabetic retinopathy.
Wade EC; Blankenship GW
Graefes Arch Clin Exp Ophthalmol; 1990; 228(3):226-31. PubMed ID: 2193849
[TBL] [Abstract][Full Text] [Related]
2. Red krypton and blue-green argon panretinal laser photocoagulation for proliferative diabetic retinopathy: a laboratory and clinical comparison.
Blankenship GW
Trans Am Ophthalmol Soc; 1986; 84():967-1003. PubMed ID: 2438841
[TBL] [Abstract][Full Text] [Related]
3. A clinical comparison of central and peripheral argon laser panretinal photocoagulation for proliferative diabetic retinopathy.
Blankenship GW
Ophthalmology; 1988 Feb; 95(2):170-7. PubMed ID: 2459641
[TBL] [Abstract][Full Text] [Related]
4. Randomized comparison of krypton versus argon scatter photocoagulation for diabetic disc neovascularization. The Krypton Argon Regression Neovascularization Study report number 1.
Ophthalmology; 1993 Nov; 100(11):1655-64. PubMed ID: 8233391
[TBL] [Abstract][Full Text] [Related]
5. Diode versus argon-green laser panretinal photocoagulation in proliferative diabetic retinopathy: a randomized study in 44 eyes with a long follow-up time.
Bandello F; Brancato R; Trabucchi G; Lattanzio R; Malegori A
Graefes Arch Clin Exp Ophthalmol; 1993 Sep; 231(9):491-4. PubMed ID: 8224951
[TBL] [Abstract][Full Text] [Related]
6. Long-term visual outcome in proliferative diabetic retinopathy patients after panretinal photocoagulation.
Dogru M; Nakamura M; Inoue M; Yamamoto M
Jpn J Ophthalmol; 1999; 43(3):217-24. PubMed ID: 10413257
[TBL] [Abstract][Full Text] [Related]
7. Red krypton and blue-green argon laser diabetic panretinal photocoagulation.
Blankenship GW; Gerke E; Batlle JF
Graefes Arch Clin Exp Ophthalmol; 1989; 227(4):364-8. PubMed ID: 2476366
[TBL] [Abstract][Full Text] [Related]
8. Posterior vitreous detachment following panretinal laser photocoagulation.
Sebag J; Buzney SM; Belyea DA; Kado M; McMeel JW; Trempe CL
Graefes Arch Clin Exp Ophthalmol; 1990; 228(1):5-8. PubMed ID: 2311946
[TBL] [Abstract][Full Text] [Related]
9. Light panretinal photocoagulation (LPRP) versus classic panretinal photocoagulation (CPRP) in proliferative diabetic retinopathy.
Bandello F; Brancato R; Menchini U; Virgili G; Lanzetta P; Ferrari E; Incorvaia C
Semin Ophthalmol; 2001 Mar; 16(1):12-8. PubMed ID: 15487693
[TBL] [Abstract][Full Text] [Related]
10. Argon laser panretinal photocoagulation in ischemic central retinal vein occlusion. A 10-year prospective study.
Hayreh SS; Klugman MR; Podhajsky P; Servais GE; Perkins ES
Graefes Arch Clin Exp Ophthalmol; 1990; 228(4):281-96. PubMed ID: 1698170
[TBL] [Abstract][Full Text] [Related]
11. Macular detachment following laser treatment for proliferative diabetic retinopathy.
Elliott A; Flanagan D
Graefes Arch Clin Exp Ophthalmol; 1990; 228(5):438-41. PubMed ID: 2227487
[TBL] [Abstract][Full Text] [Related]
12. Panretinal photocoagulation combined with intravitreal bevacizumab in high-risk proliferative diabetic retinopathy.
Cho WB; Oh SB; Moon JW; Kim HC
Retina; 2009 Apr; 29(4):516-22. PubMed ID: 19262436
[TBL] [Abstract][Full Text] [Related]
13. Central visual field changes after panretinal photocoagulation in proliferative diabetic retinopathy.
Theodossiadis GP; Boudouri A; Georgopoulos G; Koutsandrea C
Ophthalmologica; 1990; 201(2):71-8. PubMed ID: 2234818
[TBL] [Abstract][Full Text] [Related]
14. Factors Associated with Worsening Proliferative Diabetic Retinopathy in Eyes Treated with Panretinal Photocoagulation or Ranibizumab.
Bressler SB; Beaulieu WT; Glassman AR; Gross JG; Jampol LM; Melia M; Peters MA; Rauser ME;
Ophthalmology; 2017 Apr; 124(4):431-439. PubMed ID: 28161147
[TBL] [Abstract][Full Text] [Related]
15. Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
; Gross JG; Glassman AR; Jampol LM; Inusah S; Aiello LP; Antoszyk AN; Baker CW; Berger BB; Bressler NM; Browning D; Elman MJ; Ferris FL; Friedman SM; Marcus DM; Melia M; Stockdale CR; Sun JK; Beck RW
JAMA; 2015 Nov; 314(20):2137-2146. PubMed ID: 26565927
[TBL] [Abstract][Full Text] [Related]
16. Retinal blood flow regulation and the clinical response to panretinal photocoagulation in proliferative diabetic retinopathy.
Grunwald JE; Brucker AJ; Petrig BL; Riva CE
Ophthalmology; 1989 Oct; 96(10):1518-22. PubMed ID: 2587047
[TBL] [Abstract][Full Text] [Related]
17. Vitrectomy for proliferative diabetic retinopathy with severe equatorial fibrovascular proliferation.
Han DP; Pulido JS; Mieler WF; Johnson MW
Am J Ophthalmol; 1995 May; 119(5):563-70. PubMed ID: 7733181
[TBL] [Abstract][Full Text] [Related]
18. Ranibizumab Plus Panretinal Photocoagulation versus Panretinal Photocoagulation Alone for High-Risk Proliferative Diabetic Retinopathy (PROTEUS Study).
Figueira J; Fletcher E; Massin P; Silva R; Bandello F; Midena E; Varano M; Sivaprasad S; Eleftheriadis H; Menon G; Amaro M; Ayello Scheer S; Creuzot-Garcher C; Nascimento J; Alves D; Nunes S; Lobo C; Cunha-Vaz J;
Ophthalmology; 2018 May; 125(5):691-700. PubMed ID: 29395119
[TBL] [Abstract][Full Text] [Related]
19. Identifying maculopathy after neodymium: YAG membranotomy for dense diabetic premacular hemorrhage.
Ezra E; Dowler JG; Burgess F; Sehmi K; Hamilton PA
Ophthalmology; 1996 Oct; 103(10):1568-74. PubMed ID: 8874428
[TBL] [Abstract][Full Text] [Related]
20. Treatment of proliferative diabetic retinopathy. Long-term results of argon laser photocoagulation.
Little HL
Ophthalmology; 1985 Feb; 92(2):279-83. PubMed ID: 2580259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
